« Back to Record
Citation APA

Hoornaert, C. C., Verbeeck, L., Quarta, A., De Vocht, N., Lemmens, E., Goossens, H., van der linden, A., Roobrouck, V. V., Verfaillie, C., Hendrix, S., Moser, M., Luyckx, E., Berneman, Z. N., Ponsaerts, P., Reekmans, K., Dhainaut, M., Guglielmetti, C., Le Blon, D., Dooley, D., Fransen, E., & Daans, J. (2016). In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants. Stem cells, 34(7), 1971-1984. doi:10.1002/stem.2360


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/245752

Hoornaert, C. C., Verbeeck, L., Quarta, A., De Vocht, N., Lemmens, E., Goossens, H., van der linden, A., Roobrouck, V. V., Verfaillie, C., Hendrix, S., Moser, M., Luyckx, E., Berneman, Z. N., Ponsaerts, P., Reekmans, K., Dhainaut, M., Guglielmetti, C., Le Blon, D., Dooley, D., Fransen, E., & Daans, J. (2016). In Vivo Interleukin-13-Primed Macrophages Contribute to Reduced Alloantigen-Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants. Stem cells, 34(7), 1971-1984. doi:10.1002/stem.2360